MicroRNAs present exciting opportunities for cancer therapy and diagnosis

As many as 50 percent of all human protein-coding genes are regulated by microRNA (miRNA) molecules. While some miRNAs impact onset and progression of cancer, others can actually suppress the development of malignant tumors and are useful in cancer therapy. They can also serve as potential biomarkers for early cancer detection. In a new study, researchers report on non-coding miRNAs as appealing biomarkers for malignancy.

Read the whole article on Science Daily

More from Science Daily